InChI=1S/C35H47NO10/c1-14-10-9-11-15(2)35(46)36-22-13-23(37)24-25(32(43)21(8)33(44)26(24)34(22)45)29(40)17(4)12-16(3)28(39)19(6)31(42)20(7)30(41)18(5)27(14)38/h9-14,16,18-21,27-28,30-31,33,38-39,41-44H,1-8H3,(H,36,46)/b10-9+,15-11-,17-12-/t14-,16-,18+,19+,20+,21?,27-,28-,30+,31+,33?/m0/s1 |
MHOUUNHTVCQAIF-BTYVTDDSSA-N |
C[C@H]1\C=C\C=C(C)/C(=O)NC2=CC(=O)C3=C(C(O)C(C)C(O)=C3C(=O)\C(C)=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](O)[C@H](C)[C@H]1O)C2=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(6Z,8E,10S,11S,12R,13R,14R,15R,16R,17S,18S,19Z)-11,13,15,17,22,24-hexahydroxy-6,10,12,14,16,18,20,23-octamethyl-11,12,13,14,15,16,17,18,23,24-decahydro-1H-3,25-methano-4-benzazacyclotricosine-1,5,21,26(4H,10H)-tetrone
|
Proansamycin X
|
KEGG COMPOUND
|
proansamycin X
|
UniProt
|
246255-43-6
|
CAS Registry Number
|
KEGG COMPOUND
|
10430893
|
PubMed citation
|
SUBMITTER
|
16681144
|
PubMed citation
|
Europe PMC
|
|